Therapy using stem cells for the treatment of chronic kidney failure
DOI:
https://doi.org/10.33448/rsd-v12i11.43729Keywords:
Renal insufficiency chronic; Renal replacement therapy; Mesenchymal stem cells.Abstract
This study aimed to describe an alternative therapy for patients with Chronic kidney disease (CKD) using stem cells (ST). To carry out this integrative literature review, articles were surveyed in the following databases: PubMed, Scientific Electronic Library Online (Scielo), Coordination for the Improvement of Higher Education Personnel (CIHEP), Virtual Health Library (VHL). The survey took place between the months of February and September 2023. Chronic kidney disease is the result of progressive and irreversible damage to the nephrons and complications, individuals affected by CKD require adaptation in their lifestyle habits, such as following a restrictive diet, continuous use of medications and are dependent on equipment. Renal Replacement Therapies (RRT) are the treatments commonly used for CKD, namely hemolysis or peritoneal dialysis, another way of RRT currently is kidney transplantation. Despite being very effective, these treatments interfere with the quality of life and physical and mental well-being of patients. The effectiveness of treatment for CKD using CT has the great potential to repair kidney injuries, reducing the development and progression of the disease, acting to improve kidney functions. We conclude that stem cells have great potential as therapeutic agents for people with CKD, in animal and pre-clinical studies, however, given this, there is a need for more studies in humans, to prove the viability, safety and efficacy of CT.
References
Aghajani Nargesi, A., Lerman, L. O., & Eirin, A. (2017). Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges. Stem cell research & therapy, 8(1), 273. https://doi.org/10.1186/s13287-017-0727-7.
Baar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., van der Pluijm, I., Essers, J., van Cappellen, W. A., van IJcken, W. F., Houtsmuller, A. B., Pothof, J., de Bruin, R. W. F., Madl, T., Hoeijmakers, J. H. J., Campisi, J., & de Keizer, P. L. J. (2017). Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell, 169(1), 132–147.e16. https://doi.org/10.1016/j.cell.2017.02.031.
Barbosa, G. S., & Valadares, G. V. (2009). Experimentando atitudes e sentimentos: o cotidiano hemodialítico como base para o cuidar em enfermagem. Escola Anna Nery Revista de Enfermagem. 13(1), 17-23. https://doi.org/10.1590/S1414-81452009000100003.
Bastos, M.G., Bregman, R., & Kirsztajn, G. M. (2010). Doença renal crônica: frequente e grave, mas também prevenível e tratável. Revista da Associação Médica Brasileira, 56(2), 248-253. https://doi.org/10.1590/S0104-42302010000200028
Chen, F., Chen, N., Xia, C., Wang, H., Shao, L., Zhou, C., & Wang, J. (2023). Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges. Cell transplantation, 32, 9636897231164251. https://doi.org/10.1177/0963689723116425.
Eirin, A., & Lerman, L. O. (2014). Mesenchymal stem cell treatment for chronic renal failure. Stem cell research & therapy, 5(4), 83. https://doi.org/10.1186/scrt472.
Fachin, O. (2017). Fundamentos da Metodologia Cientifica: noções básicas em pesquisa cietifica. (6a ed.) Saraiva.
Fleig, S. V., & Humphreys, B. D. (2014). Rationale of mesenchymal stem cell therapy in kidney injury. Nephron. Clinical practice, 127(1-4), 75–80. https://doi.org/10.1159/000363680.
Franco, M. L., Beyerstedt, S., & Rangel, É. B. (2021). Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease. Pharmaceutics, 14(1), 11. https://doi.org/10.3390/pharmaceutics14010011.
Grange, C., Tritta, S., Tapparo, M., Cedrino, M., Tetta, C., Camussi, G., & Brizzi, M. F. (2019). Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy. Scientific reports, 9(1), 4468. https://doi.org/10.1038/s41598-019-41100-9.
Grange, C., Skovronova, R., Marabese, F., & Bussolati, B. (2019). Stem Cell-Derived Extracellular Vesicles and Kidney Regeneration. Cells, 8(10), 1240. https://doi.org/10.3390/cells8101240.
Gil, AC. (2019). Como elaborar Projetos de Pesquisa.(6a ed.) Atlas.
Guo, J., Wang, R., & Liu, D. (2021). Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Sepsis-Induced Acute Kidney Injury by Promoting Mitophagy of Renal Tubular Epithelial Cells via the SIRT1/Parkin Axis. Frontiers in endocrinology, 12, 639165. https://doi.org/10.3389/fendo.2021.639165.
Harari-Steinberg, O., Pleniceanu, O., & Dekel, B. (2011). Selecting the optimal cell for kidney regeneration: fetal, adult or reprogrammed stem cells. Organogenesis, 7(2), 123–134. https://doi.org/10.4161/org.7.2.15783.
Hickson, L. J., Eirin, A., & Lerman, L. O. (2016). Challenges and opportunities for stem cell therapy in patients with chronic kidney disease. Kidney international, 89(4), 767–778. https://doi.org/10.1016/j.kint.2015.11.023.
Huang, Y., & Yang, L. (2021). Mesenchymal stem cells and extracelular vesicles in therapy against kidney diseases. Stem Cell Research & Therapy, 12(219), 1-12. https://doi.org/10.1186/s13287-021-02289-7.
Kdigo. (2012). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Official Journal of the international society of nephrology.
Liu, D., Cheng, F., Pan, S., & Liu, Z. (2020). Stem cells: a potential treatment option for kidney diseases. Stem cell research & therapy, 11(1), 249. https://doi.org/10.1186/s13287-020-01751-2.
Martos-Rus, C., Katz-Greenberg, G., Lin, Z., Serrano, E., Whitaker-Menezes, D., Domingo-Vidal, M., & Martinez Cantarin, M. P. (2021). Macrophage and adipocyte interaction as a source of inflammation in kidney disease. Sci Rep, 11(1), 2974. https://doi.org/10.1038/s41598-021-82685-4.
Monteiro, B. S., Argolo Neto, N. M., & Del Carlo, R. J. (2010). Células-tronco mesenquimais. Ciência Rural, 40(1), 238–245. https://doi.org/10.1590/S0103-84782010000100040.
Pino, C. J., & Humes, H. D. (2010). Stem cell technology for the treatment of acute and chronic renal failure. Translational research : the journal of laboratory and clinical medicine, 156(3), 161–168. https://doi.org/10.1016/j.trsl.2010.07.005.
Prates, A. B., Amaral, F. B., Vacaro, M. Z., Gross, J. L., Camargo, J. L., & Silveiro, S. P. (2007). Avaliação da Filtração Glomerular Através da Medida da Cistatina C Sérica. Braz. J. Nephrol., 29(1), 48-55. https://bjnephrology.org/wp-content/uploads/2019/08/jbn_v29n1a10.pdf.
Quintana, A. M., Weissheimer, T. K. dos S., & Hermann, C. (2011). Atribuições de significados ao transplante renal. Psico, 42(1). Recuperado de https://revistaseletronicas.pucrs.br/ojs/index.php/revistapsico/article/view/6057.
Ribeiro, P. C., Lojudice, F. H., Fernandes-Charpiot, I. M. M., Baptista, M. A. S. F., de Almeida Araújo, S., Mendes, G. E. F., Sogayar, M. C., Abbud-Filho, M., & Caldas, H. C. (2020). Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease. Stem cell research & therapy, 11(1), 530. https://doi.org/10.1186/s13287-020-02060-4.
Sahay, M., Kalra, S., & Bandgar, T. (2012). Renal endocrinology: The new frontier. Indian Journal of Endocrinology and Metabolism, 16(2), 154-155. 10.4103/2230-8210.93729.
Semedo, P., Costa, M. C., Cenedeze, M. A., Malheiros, D. M. A. C., Reis, M. A., Shimizu, M. H., Seguro, A. C., Silva, A. P., & Câmara, N. O. S. (2009). Mesenchymal Stem Cells Attenuate Renal Fibrosis Through Immune Modulation and Remodeling Properties in a Rat Remnant Kidney Model. Stem Cell Research & Therapy, 27(12), 3063–3073. https://doi.org/10.1002/stem.214.
Singh, J., & Singh, S. (2023). Review on kidney diseases: types, treatment and potential of stem cell therapy. Renal Replacement Therapy, 9(21). https://doi.org/10.1186/s41100-023-00475-2.
Sodré, F. L., Costa, J. C. B., & Lima, J. C. C. (2007). Avaliação da função e da lesão renal: um desafio laboratorial. Jornal Brasileiro de Patologia e Medicina Laboratorial, 43 (5), 329-337. https://doi.org/10.1590/S1676-24442007000500005.
Song, T., Eirin, A., Zhu, X., Zhao, Y., Krier, J. D., Tang, H., Jordan, K. L., Woollard, J. R., Taner, T., Lerman, A., & Lerman, L. O. (2020). Mesenchymal Stem Cell-Derived Extracellular Vesicles Induce Regulatory T Cells to Ameliorate Chronic Kidney Injury. Hypertension (Dallas, Tex. : 1979), 75(5), 1223–1232. https://doi.org/10.1161/HYPERTENSIONAHA.119.14546.
Torrico, S., Hotter, G., & Játiva, S. (2022). Development of Cell Therapies for Renal Disease and Regenerative Medicine. International journal of molecular sciences, 23(24), 15943. https://doi.org/10.3390/ijms232415943.
Torres Crigna, A., Daniele, C., Gamez, C., Medina Balbuena, S., Pastene, D. O., Nardozi, D., Brenna, C., Yard, B., Gretz, N., & Bieback, K. (2018). Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models. Frontiers in medicine, 5, 179. https://doi.org/10.3389/fmed.2018.00179.
Xing, L., Cui, R., Peng, L., Ma, J., Chen, X., Xie, R. J., & Li, B. (2014). Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury. Stem cell research & therapy, 5(4), 101. https://doi.org/10.1186/scrt489.
Yang, W. Y., Chen, L. C., Jhuang, Y. T., Lin, Y. J., Hung, P. Y., Ko, Y. C., Tsai, M. Y., Lee, Y. W., Hsu, L. W., Yeh, C. K., Hsu, H. H., & Huang, C. C. (2021). Injection of hybrid 3D spheroids composed of podocytes, mesenchymal stem cells, and vascular endothelial cells into the renal cortex improves kidney function and replenishes glomerular podocytes. Bioengineering & translational medicine, 6(2), e10212. https://doi.org/10.1002/btm2.10212.
Yun, C. W., & Lee, S. H. (2019). Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease. International journal of molecular sciences, 20(7), 1619. https://doi.org/10.3390/ijms20071619.
Zhang, Z., Yang, C., Shen, M., Yang, M., Jin, Z., Ding, L., Jiang, W., Yang, J., Chen, H., Cao, F., & Hu, T. (2017). Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction. Stem cell research & therapy, 8(1), 89. https://doi.org/10.1186/s13287-017-0543-0.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Bruna Gomes Pereira; Thais Aiko Waragaya ; Gabriel Lopes Pinto; Mariana Araújo Muscalu; Giovanna Santos da Silva; Ana Luiza Santos Maldonado
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
